[Monoamine oxidase and its inhibitors. Physiological, physiopathological and pharmacotherapeutic considerations].
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D050356:Lipid Metabolism; D001523:Mental Disorders / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D008995:Monoamine Oxidase / Q000378:metabolism / Q000502:physiology*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D051381:Rats; D012701:Serotonin / Q000378:metabolism
D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D008995:Monoamine Oxidase; D004298:Dopamine
Monoaminooxidaza şi inhibitorii acesteia. Consideraţii fiziologice, fiziopatologice şi farmacoterapeutice.